Literature DB >> 27122667

Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.

Abdel-Rahman Nabawy Zekri1, Amira Salah El-Din Youssef1, Yasser Mabrouk Bakr1, Reham Mohamed Gabr1, Ola Sayed Ahmed1, Mostafa Hamed Elberry1, Ahmed Mahmoud Mayla1, Mohamed Abouelhoda1, Abeer A Bahnassy1.   

Abstract

AIM: To develop a mathematical model for the early detection of hepatocellular carcinoma (HCC) with a panel of serum proteins in combination with α-fetoprotein (AFP).
METHODS: Serum levels of interleukin (IL)-8, soluble intercellular adhesion molecule-1 (sICAM-1), soluble tumor necrosis factor receptor II (sTNF-RII), proteasome, and β-catenin were measured in 479 subjects categorized into four groups: (1) HCC concurrent with hepatitis C virus (HCV) infection (n = 192); (2) HCV related liver cirrhosis (LC) (n = 96); (3) Chronic hepatitis C (CHC) (n = 96); and (4) Healthy controls (n = 95). The R package and different modules for binary and multi-class classifiers based on generalized linear models were used to model the data. Predictive power was used to evaluate the performance of the model. Receiver operating characteristic curve analysis over pairs of groups was used to identify the best cutoffs differentiating the different groups.
RESULTS: We revealed mathematical models, based on a binary classifier, made up of a unique panel of serum proteins that improved the individual performance of AFP in discriminating HCC patients from patients with chronic liver disease either with or without cirrhosis. We discriminated the HCC group from the cirrhotic liver group using a mathematical model (-11.3 + 7.38 × Prot + 0.00108 × sICAM + 0.2574 × β-catenin + 0.01597 × AFP) with a cutoff of 0.6552, which achieved 98.8% specificity and 89.1% sensitivity. For the discrimination of the HCC group from the CHC group, we used a mathematical model [-10.40 + 1.416 × proteasome + 0.002024 × IL + 0.004096 × sICAM-1 + (4.251 × 10(-4)) × sTNF + 0.02567 × β-catenin + 0.02442 × AFP] with a cutoff 0.744 and achieved 96.8% specificity and 89.7% sensitivity. Additionally, we derived an algorithm, based on a binary classifier, for resolving the multi-class classification problem by using three successive mathematical model predictions of liver disease status.
CONCLUSION: Our proposed mathematical model may be a useful method for the early detection of different statuses of liver disease co-occurring with HCV infection.

Entities:  

Keywords:  Hepatocellular carcinoma; Interleukin-8; Mathematical model; Proteasome; Soluble intercellular adhesion molecule-1; Soluble tumor necrosis factor receptor II; α-fetoprotein; β-catenin

Mesh:

Substances:

Year:  2016        PMID: 27122667      PMCID: PMC4837434          DOI: 10.3748/wjg.v22.i16.4168

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

Review 1.  Metabolomics: available results, current research projects in breast cancer, and future applications.

Authors:  Wederson Marcos Claudino; Alessandro Quattrone; Laura Biganzoli; Marta Pestrin; Ivano Bertini; Angelo Di Leo
Journal:  J Clin Oncol       Date:  2007-05-14       Impact factor: 44.544

2.  The Role of Inflammation in the Pathogenesis of Colorectal Cancer.

Authors:  Beth B McConnell; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2009-04-01

Review 3.  Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.

Authors:  Taro Yamashita; Masao Honda; Shuichi Kaneko
Journal:  J Gastroenterol Hepatol       Date:  2011-06       Impact factor: 4.029

4.  Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.

Authors:  Abdel-Rahman Zekri; Amira Salah El-Din Youssef; Yasser Mabrouk Bakr; Reham Mohamed Gabr; Mahmoud Nour El-Din El-Rouby; Ibtisam Hammad; Entsar Abd El-Monaem Ahmed; Hanan Abd El-Haleem Marzouk; Mohammed Mahmoud Nabil; Hanan Abd El-Hafez Hamed; Yasser Hamada Ahmed Aly; Khaled S Zachariah; Gamal Esmat
Journal:  Asian Pac J Cancer Prev       Date:  2015

5.  Clinical significance of axin and β-catenin protein expression in primary hepatocellular carcinomas.

Authors:  Cheng-Nong Guan; Xin-Ming Chen; Hai-Qing Lou; Xiang-Hui Liao; Bao-Ying Chen; Pei-Weng Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2012

6.  Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.

Authors:  Abdel-Rahman N Zekri; Abeer A Bahnassy; Sabrin A Abdel-Wahab; Medhat M Khafagy; Samah A Loutfy; Hessam Radwan; Sabry M Shaarawy
Journal:  J Gastroenterol Hepatol       Date:  2008-11-27       Impact factor: 4.029

7.  Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma.

Authors:  Peifeng Li; Yongcheng Cao; Yamin Li; Luting Zhou; Xiaohong Liu; Ming Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-05-25

Review 8.  ICAM-1 signaling in endothelial cells.

Authors:  Charlotte Lawson; Sabine Wolf
Journal:  Pharmacol Rep       Date:  2009 Jan-Feb       Impact factor: 3.024

9.  Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.

Authors:  Ashlyn J Bernier; Jing Zhang; Erik Lillehoj; Andrew R E Shaw; Nirosha Gunasekara; Judith C Hugh
Journal:  Mol Cancer       Date:  2011-07-28       Impact factor: 27.401

10.  Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.

Authors:  Abdel-Rahman N Zekri; Hanaa M Alam El-Din; Abeer A Bahnassy; Naglaa A Zayed; Waleed S Mohamed; Suzan H El-Masry; Sayed K Gouda; Gamal Esmat
Journal:  Comp Hepatol       Date:  2010-01-05
View more
  1 in total

1.  Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma.

Authors:  Weiwei Cao; Yu Chen; Wei Han; Juzheng Yuan; Weimin Xie; Kun Liu; Yan Qiu; Xudan Wang; Xiao Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.